Position
Chief Medical Officer
Company
TOLREMO therapeutics
BaselBiotechnologyHealth CareTherapeuticsDescription
TOLREMO therapeutics AG has appointed Florian D. Vogl as Chief Medical Officer, succeeding Alessandra Cesano, who will join the company’s Board of Directors. With extensive experience in the biopharmaceutical industry, Vogl is expected to strengthen TOLREMO’s executive team and advance its mission.
Quick answer
TOLREMO Appoints Florian D. Vogl as Chief Medical Officer (June 18, 2025). TOLREMO therapeutics is based in Basel, Basel City, Switzerland.
- Who is the new Chief Medical Officer at TOLREMO therapeutics?
- TOLREMO therapeutics named Florian D. Vogl Chief Medical Officer, announced June 18, 2025.
- What did TOLREMO therapeutics announce on June 18, 2025?
- TOLREMO therapeutics AG has appointed Florian D. Vogl as Chief Medical Officer, succeeding Alessandra Cesano, who will join the company’s Board of Directors. With extensive experience in the biopharmaceutical industry, Vogl is expected to strengthen TOLREMO’s executive team and advance its mission.
- What does TOLREMO therapeutics do?
- TOLREMO therapeutics AG is a clinical-stage company dedicated to developing treatments to prevent transcriptional cancer drug resistance.
- Where is TOLREMO therapeutics based?
- TOLREMO therapeutics is based in Basel, Basel City, Switzerland.
- Which similar companies made leadership changes around the same time?
- Atalanta Therapeutics (June 18, 2025), Alnylam Pharmaceuticals (June 19, 2025), Solu Therapeutics (June 16, 2025) and OnCusp Therapeutics (June 23, 2025) also announced leadership changes within 45 days of TOLREMO therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Atalanta Therapeutics Appoints Joanne Kotz as Chief Executive Officer and Douglas Pagán as Chief Financial Officer & Chief Operating Officer (June 18, 2025)
- Alnylam Pharmaceuticals Appoints Pushkal Garg as Chief Research and Development Officer (June 19, 2025)
- Solu Therapeutics Appoints Enda Moran as Chief Operating Officer (June 16, 2025)
- OnCusp Therapeutics Appoints Dimitry S.A. Nuyten as Chief Medical Officer (June 23, 2025)
- Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer (June 23, 2025)
- Ascidian Therapeutics Appoints Murray A. Abramson as Chief Development Officer (June 24, 2025)
Who to call at TOLREMO therapeutics, and when
A new leader at TOLREMO therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day TOLREMO therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TOLREMO therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TOLREMO therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TOLREMO therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TOLREMO therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.